Medicxi has 3 portfolio companies on record at Recent Funding, with 2 investments in the last 12 months.

About this page

It led 1 of the 4 rounds it joined. Its most recent investment on record is Vaderis Therapeutics's $152M Series B+ round in August 2026, alongside Kalehua Capital, EQT Life Sciences, Droia Ventures and 4 others. By category, its portfolio leans toward Health and bio (3) and Education (1). It has co-invested with Wellington Management, OrbiMed and SR One, most often Wellington Management (3 rounds).

What Medicxi invests in

• Health and bio · 3 · 100%
• Education · 1 · 33%

Medicxi recent investments

Company	Round	Date	Alongside
VVaderis Therapeutics	Series B+ · $152M	Aug 11, 2026	Kalehua Capital, EQT Life Sciences, Droia Ventures +4
FFore Biotherapeutics	Series B+ · $67.4M	Jul 8, 2026	Windham Venture Partners, Wellington Management, Novartis Venture Fund +6
FFore Biotherapeutics	Series B+ · $40M	May 1, 2025	Wellington Management, Novartis Venture Fund, HBM Healthcare Investments +4
FFore Biotherapeutics	Series B+ · $75M · lead	Aug 23, 2023	Wellington Management, Novartis Venture Fund, Samsung Securities +5

How Medicxi invests

Medicxi portfolio companies

• VVaderis Therapeutics$152MSeries B+ · Aug 2026
• FFore Biotherapeutics$67.4MSeries B+ · Jul 2026
• CCurevo Vaccinebacker

Most frequent co-investors

• WWellington Management3 shared rounds · last Jul 8, 2026
• OOrbiMed3 shared rounds · last Jul 8, 2026
• SSR One3 shared rounds · last Jul 8, 2026
• NNovartis Venture Fund3 shared rounds · last Jul 8, 2026
• SSamsung Securities2 shared rounds · last Jul 8, 2026
• 33B Future Health Fund2 shared rounds · last May 1, 2025
• CCormorant Asset Management2 shared rounds · last May 1, 2025
• PPerceptive Advisors1 shared round · last Aug 11, 2026
• OOmega Funds1 shared round · last Aug 11, 2026
• EEQT Life Sciences1 shared round · last Aug 11, 2026
• DDroia Ventures1 shared round · last Aug 11, 2026
• TTCG Crossover1 shared round · last Aug 11, 2026

Similar investors

• AAble Partners3 companies · 1 deal in 12 mo
• OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
• SSide Stage Ventures3 companies
• IIzou Partners2 companies · 2 deals in 12 mo
• TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
• BBdc Thrive venture5 companies · 3 deals in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 4 rounds on Recent Funding that name Medicxi. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Medicxi, which is a subset of its real portfolio. API: /api/v1/investors/medicxi (get a free API key). More: the most active VC firms and new venture capital funds.